ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q1SCImago #6,962Gold OA

Dermatologic Therapy

Acronym:dth
•
Abbreviation (ISO):DERMATOL THER
•
Identifier (ISSN):1396-0296(Print)/1529-8019(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
1↓ -2.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Dermatologic Therapy

WoS Q4
02351.5520181.7420192.3320202.8520213.8620223.620233.720243.4202512026
Annual Impact Factor Metric
Current (2026):1
Scopus SJR & RankScopus Q1
0.796
#6,962

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
90

90 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
350articles/year
100% Gold OA•77.25% Original Research

Aims & Scope

Dermatologic Therapy has been created to fill an important void in the dermatologic literature: the lack of a readily available source of up-to-date information on the treatment of specific cutaneous diseases and the practical application of specific treatment modalities. Each issue of the journal consists of a series of scholarly review articles written by leaders in dermatology in which they describe, in very specific terms, how they treat particular cutaneous diseases and how they use specific therapeutic agents. The information contained in each issue is so practical and detailed that the reader should be able to directly apply various treatment approaches to daily clinical situations. Because of the specific and practical nature of this publication, Dermatologic Therapy not only serves as a readily available resource for the day-to-day treatment of patients, but also as an evolving therapeutic textbook for the treatment of dermatologic diseases.

Topics Covered (Recognized by AI)
Medicine99.7%Biology85.4%Dermatology82.9%Internal medicine69.6%Pathology63%Immunology53.1%Genetics48.4%Surgery44.8%Chemistry29.3%Disease28.5%Biochemistry22.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

DERMATOLOGY

Q4
Rank75/99
IndexSCIE
JCISCIE2026

DERMATOLOGY

Q1
Rank16/99
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1
Articles / Year280
Total Citations20
2025
IF3.4
Articles / Year122
Total Citations115
2024
IF3.7
Articles / Year67
Total Citations150
2023
IF3.6
Articles / Year81
Total Citations228
2022
IF3.858
Articles / Year694
Total Citations6,405

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,962Scopus Q1SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
0.796

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
1.01

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,160 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,924
3-Year Documents919
Citable Documents554

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

DermatologyQ1
Medicine (miscellaneous)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区DERMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Dermatologic Therapy (acronym: dth, abbr: DERMATOL THER, ISSN: 1396-0296) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in United States since 1996. The periodical holds a Journal Impact Factor (JIF) of 1.00, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.796 (Q1), an H-index of 90.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 350 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,160 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
1996
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d6015e18-3c83-4b75-9863-68ae8665ad33
Database Updated: 2026-10-01